SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
Economic evaluation of donepezil in moderate to severe Alzheimer disease
10 references·1 citing·35 second hop
Economic evaluation of donepezil in moderate to severe Alzheimer disease (2004)Economic evaluation of donepezil in moder…An Economic Evaluation of Donepezil in Mild to Moderate Alzheimer’s Disease: Results of a 1-Year, Double-Blind, Randomized Trial (2002)An Economic Evaluation of Don…How should cost data in pragmatic randomised trials be analysed? (2000)How should cost data in pragm…Economic evaluation and clinical trials: size matters (2000)Economic evaluation and clini…The cost-effectiveness of donepezil therapy in Swedish patients with Alzheimer's disease: A Markov model (1999)The cost-effectiveness of don…Economic Evaluation of Donepezil for the Treatment of Alzheimer's Disease in Canada (1999)Economic Evaluation of Donepe…Cost-effectiveness of donepezil in the treatment of mild or moderate Alzheimer’s disease (1999)Cost-effectiveness of donepez…Pharmacotherapy for people with Alzheimer's disease: a Markov-cycle evaluation of five years' therapy using donepezil (1998)Pharmacotherapy for people wi…Estimating country-specific cost-effectiveness from multinational clinical trials (1998)Estimating country-specific c…Estimating Costs in Cost Effectiveness Analysis (1996)Estimating Costs in Cost Effe…Reliability of a Standardized Mini-Mental State Examination compared with the traditional Mini-Mental State Examination (1991)Reliability of a Standardized…Health economic evaluation of treatments for Alzheimer′s disease: impact of new diagnostic criteria (2014)Health economic evaluation of…Clinical Decision Analysis (1980)Markov Models in Medical Decision Making (1993)Usefulness of US Cost-of-Illness Studies in Healthcare Decision Making (2001)Methods for the Economic Evaluation of Health Care Programmes (2005)Methodological considerations in cost of illness studies on Alzheimer disease (2012)The Distribution of Health Care Costs and Their Statistical Analysis for Economic Evaluation (1998)Randomised controlled trial of non-directive counselling, cognitive-behaviour therapy, and usual general practitioner care for patients with depression. I: Clinical effectiveness (2000)Randomised controlled trial of non-directive counselling, cognitive-behaviour therapy, and usual general practitioner care for patients with depression. II: Cost effectiveness (2000)Effectiveness and cost effectiveness of counselling in primary care (2002)Evidence of cost-effective treatments for depression: a systematic review (2004)Health economics of dementia (1998)Model-Based Economic Evaluation in Alzheimer's Disease: A Review of the Methods Available to Model Alzheimer's Disease Progression (2011)Economic Evaluation of Treatment Options in Patients with Alzheimerʼs Disease (2012)Cost-Effectiveness in Health and Medicine (1996)Recommendations of the Panel on Cost-Effectiveness in Health and Medicine (1996)BAYESIAN VALUE-OF-INFORMATION ANALYSIS (2001)When should decision-analytic modeling be used in the economic evaluation of health care? (2003)Common Methodological Flaws in Economic Evaluations (2005)Uncertainty in the economic evaluation of health care technologies: The role of sensitivity analysis (1994)Economic Evaluation of Mental Health Care (2001)Discrete Latent Markov Models for Normally Distributed Response Data (2005)Nixon, Richard M. (1999)Development of WHO guidelines on generalized cost-effectiveness analysis (2000)Assessing generalisability by location in trial‐based cost‐effectiveness analysis: the use of multilevel models (2004)The Economics of Priority Setting for Health Care : A Literature Review (2004)Conducting economic evaluations alongside multinational clinical trials: Toward a research consensus (2005)Assessment of patient capacity to consent to treatment (1999)Current State of Research on Decision-Making Competence of Cognitively Impaired Elderly Persons (2002)Rating scales in old age psychiatry (2002)Financial cost of social exclusion: follow up study of antisocial children into adulthood (2001)Mindfulness-based cognitive therapy to prevent relapse in recurrent depression. (2008)Review of statistical methods for analysing healthcare resources and costs (2010)Economic valuation of informal care: Lessons from the application of the opportunity costs and proxy good methods (2005)Monetary valuation of informal care: the well‐being valuation method (2007)Good Research Practices for Measuring Drug Costs in Cost-Effectiveness Analyses: A Societal Perspective: The ISPOR Drug Cost Task Force Report—Part II (2009)
this work references cited by second hop

References

  • 2000How should cost data in pragmatic randomised trials be analysed?771 cited
  • 1991Reliability of a Standardized Mini-Mental State Examination compared with the traditional Mini-Mental State Examination647 cited
  • 1999Cost-effectiveness of donepezil in the treatment of mild or moderate Alzheimer’s disease244 cited
  • 1996Estimating Costs in Cost Effectiveness Analysis229 cited
  • 2000Economic evaluation and clinical trials: size matters224 cited
  • 1998Estimating country-specific cost-effectiveness from multinational clinical trials125 cited
  • 1999Economic Evaluation of Donepezil for the Treatment of Alzheimer's Disease in Canada125 cited
  • 2002An Economic Evaluation of Donepezil in Mild to Moderate Alzheimer’s Disease: Results of a 1-Year, Double-Blind, Randomized Trial112 cited
  • 1999The cost-effectiveness of donepezil therapy in Swedish patients with Alzheimer's disease: A Markov model96 cited
  • 1998Pharmacotherapy for people with Alzheimer's disease: a Markov-cycle evaluation of five years' therapy using donepezil92 cited

Cited by

  • 2014Health economic evaluation of treatments for Alzheimer′s disease: impact of new diagnostic criteria81 cited

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work